Receptor activator of NF-κB (RANK) ligand (RANKL) is expressed in skin cancers of apocrine origin such as EMPD and apocrine carcinoma [180, 187] and is released in its soluble form. This evidence concerns the gene TNFSF11 and extramammary Paget disease.